UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VTRS — Viatris Inc
CIK 861177
NEW YORK, NY
Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$53,562,146
+$5,824,433 QoQ
Shares Held
3,964,630
+3.4% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 29.74660939356258.ToString("F0")%
Shared 0.ToString("F0")%
None 70.25339060643742.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $926,551,772 across 34 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,398,351 | $519,929,066 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
207,309 | $122,930,085 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
571,719 | $75,318,257 | |
| 4 | VTRS |
Viatris Inc
This page
|
3,964,630 | $53,562,146 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
486,498 | $36,900,870 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,526,922 | $36,539,240 | |
| 7 | ALKS |
Alkermes plc.
|
403,153 | $14,255,486 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
443,527 | $9,207,616 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,562,146 | 3,964,630 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,737,713 | 3,834,355 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $30,892,658 | 3,120,471 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $45,178,205 | 5,059,150 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $54,328,983 | 6,237,542 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $75,861,094 | 6,093,261 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $68,721,511 | 5,919,166 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,808,503 | 6,284,902 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,459,058 | 4,979,821 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,756,967 | 4,686,701 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $47,663,264 | 4,834,003 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $47,711,670 | 4,780,729 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $45,990,606 | 4,780,729 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,718,433 | 4,646,760 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $35,545,954 | 4,172,061 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,414,145 | 4,433,061 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $50,232,031 | 4,616,915 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $60,475,592 | 4,469,741 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $65,094,316 | 4,804,009 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $68,731,636 | 4,809,772 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $76,804,302 | 5,497,803 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $111,631,046 | 5,956,833 | Shares | Defined | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||